Venture Life Group PLC UltraDEX update (4552M)
30 April 2018 - 4:00PM
UK Regulatory
TIDMVLG
RNS Number : 4552M
Venture Life Group PLC
30 April 2018
Venture Life Group plc
("Venture Life" or "the Company")
UltraDEX update
Venture Life (AIM: VLG), the international consumer self-care
group focused on developing, manufacturing and commercialising
products for the self-care market announces an update on the
UltraDEX brand. The Company has extended its agreement with key
French distributor La Brosse et Dupont SAS ("La Brosse") to include
the UltraDEX Sensitive toothpaste. The launch will take place in H2
2018 and follows the successful launch of the original UltraDEX
range in Q1 2018 in France.
Founded in 1932, La Brosse is a former subsidiary of LVMH Moet
Hennessy Louis Vuitton S.E. It serves customers through large and
medium commercial outlets throughout France, including Leclerc and
Carrefour, and has market leading products within the oral
healthcare space. Le Brosse launched the original UltraDEX range
into the French market during March 2018 and is building up a
presence in the grocery multiples.
UltraDEX was also partnered in Italy and the Nordics in 2017,
and after delivery of product in Q4 2017, these partners have also
launched UltraDEX into their respective markets during H1 2018.
Both partners are building a presence for the mouthwash, toothpaste
and spray products in pharmacies and dentists, and early
indications are positive for the sell through.
Separately, the Company announces the launch of the new UltraDEX
'One GoÔ' range in all 797 of the Superdrug stores in the UK from
June 2018. UltraDEX 'One Go' is another new innovative line
extension from the Company, providing single use sachets of the
UltraDEX mouthwash.
Jerry Randall, CEO of Venture Life commented: "The extension of
this agreement with La Brosse is a real testament to the continued
international success of UltraDEX, particularly at such an early
stage in their launch of the UltraDEX range in France. I am
delighted with the continued commercial development of the UltraDEX
brand both in the UK and internationally, and we look forward
updating the market further throughout the rest of the year.
"It's also great news that our new product, UltraDEX 'One Go',
has been so quickly adopted by one of the leading pharmacy chains,
Superdrug, demonstrating our ability to rapidly develop and launch
innovative new products into the consumer self-care channel, and we
are hopeful to extend its presence further. Innovation is key to
the growth of consumer brands, and Venture Life has the experience
and capabilities to develop and commercialise such new
products."
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014 (MAR).
Enquiries
+44 (0) 1344 578
Venture Life Group PLC 004
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Northland Capital Partners Limited (Nominated +44 (0) 20 3861
Adviser and Joint Broker) 6625
Matthew Johnson/Edward Hutton (Corporate Finance)
Bob Pountney (Corporate Broking)
+44 (0) 20 3621
Turner Pope Investments (TPI) Ltd (Joint Broker) 4120
Andy Thacker
Walbrook PR venturelife@walbrookpr.com or +44
(0) 20 7933 8780
Anna Dunphy/Paul McManus +44 (0) 7876 741 001 / +44 (0) 7980
541 893
This information is provided by RNS
The company news service from the London Stock Exchange
END
UPDLLFLESDIDFIT
(END) Dow Jones Newswires
April 30, 2018 02:00 ET (06:00 GMT)
Venture Life (LSE:VLG)
Historical Stock Chart
From Apr 2024 to May 2024
Venture Life (LSE:VLG)
Historical Stock Chart
From May 2023 to May 2024